Elizabeth Howard's most recent trade in Arbutus Biopharma Corp was a trade of 278,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Elizabeth Howard | EVP, GC, Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 278,700 | 278,700 | - | - | Stock Option (Right to Buy) | |
| Arbutus Biopharma Corp | Elizabeth Howard | EVP, GC, Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 69,700 | 86,024 (0%) | 0% | 0 | Common Shares | |
| Arbutus Biopharma Corp | Elizabeth Howard | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 237,500 | 237,500 | - | - | Stock Option (Right to Buy) |